Exabis Library
Welcome to the e-CCO Library!
P696: Ambient air quality as risk factor for microscopic colitis – a Geographic Information System study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P696: Design and rationale for the multicentre, randomised, controlled VERDICT trial to determine the optimal treatment target in patients with ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P696: Faecal microbiota transplantation in ultra-refractory ulcerative colitis: Retrospective analysis in a tertiary care centre
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P696: Genetic predisposition to infliximab immunogenicity in patients with immune-mediated inflammatory diseases – secondary analyses from a randomised clinical trial
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P696: Long-term prognosis and predictive factors for surgical treatment of intestinal lesions in patients with Behcet’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P697 Efficacy and safety of ustekinumab in Crohn’s disease: A real-world study from Australia
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P697: Pneumocystis jirovecii pneumonia in IBD patients treated with immunomodulator(s)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P697: Association of inflammatory bowel disease and celiac disease. Experience in a hospital of the autonomous community of Madrid (Spain)
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P697: De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P697: Examining the regulatory role of epigenetic and transcriptomic alterations in anti-TNF treatment response and disease progression in patients with Ulcerative Colitis
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P697: Thiopurines vs. anti-TNFa for the prevention of postoperative recurrence in Crohn’s disease—a meta-analysis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P698 IBD patients equally tolerate bowel preparation but need higher doses of sedation during colonoscopy in comparison with a population screening programme: Results from a prospective, single-centre study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P698: Early dose optimisation in non-responders to golimumab induction treatment for ulcerative colitis is supported by pharmacokinetic data
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P698: Mapping field cancerisation and clonal evolution in IBD colons with dysplasia and colorectal cancer
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P698: Persistence, clinical effectiveness and safety of vedolizumab in the post-marketing real clinical practice in Italy: a double-centre, 2-year experience in Crohn’s disease and ulcerative colitis patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P698: Role of an exclusion diet (reduced disaccharides, saturated fats, emulsifiers, red and ultraprocessed meats) in maintaining the remission of chronic inflammatory bowel diseases in adults
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P698: The risk of developing subsequent immune mediated inflammatory diseases: a retrospective matched cohort study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P699 The concordance of Short Form-36 Health Survey scores with Mayo scores in the tofacitinib ulcerative colitis clinical programme
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P699: Faecal microbiota transplantation as treatment for recurrent clostridium difficile infections: a single-centre experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P699: Impact of adalimumab's patient support program on clinical outcomes in inflammatory bowel diseases: results from the COMPANION study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM